1
0
Quildrian SD y cols. Sarcomas de partes blandas de tronco y extremidades. Rev Argent Cir. 2026;118(2):e-1942
perform extensive resecꢀons that expose neurovascular of vital structures that have not been invaded. Gerrand
bundles or bones. An aspect to consider in these et al.30 demonstrated that this type of resecꢀon, when
paꢀents is the possibility that they may require some combined with radiaꢀon therapy, provides good local
kind of reconstrucꢀon.
control and avoids greater morbidity when planned
In this series, nearly one-third of the paꢀents preoperaꢀvely.
required a reconstrucꢀve procedure. Although local
In this series, the 5-year survival rate for
graꢁs and flaps were uꢀlized in certain cases, free flaps paꢀents treated for primary tumors was approximately
were necessary in 7% of cases to achieve adequate 80%, similar to rates reported by referral centers. In
coverage, with fasciocutaneous flaps being the most turn, the survival rates of paꢀents treated outside our
frequently employed. The decision of which procedure center were comparable to those of paꢀents iniꢀally
to use depends on local factors, the paꢀent, and the treated at our unit. However, these paꢀents required
tumor. In cases of major resecꢀons due to tumors in the more complex procedures to ensure opꢀmal surgical
distal extremiꢀes or certain areas of the chest wall, free outcomes. For this reason, it is necessary to refer them
flaps are the only reconstrucꢀve surgical opꢀon. Thus, a promptly to specialized centers.
thorough preoperaꢀve evaluaꢀon is essenꢀal to ensure
While our study has limitaꢀons common to
retrospecꢀve studies, its strength lies in the fact that it
1
7
a successful surgical outcome .
Another example
of
mulꢀdisciplinary consistsofpaꢀentstreatedatasinglecenterbyaunitwith
surgical management is the assessment of vascular experꢀse in sarcoma management. We believe that our
involvement. In our series, 3 paꢀents required vascular results can be aꢄributed to our iniꢀal mulꢀdisciplinary
resecꢀon with reconstrucꢀon. In most cases, an approach and adherence to clinical guidelines. We
advenꢀꢀal dissecꢀon can be performed if there is no emphasize the importance of having a team specialized
direct vascular involvement. This type of dissecꢀon is in the management of sarcomas, as well as the ability
also used on nerve structures and bone when there to collaborate with other surgical specialꢀes, such
is no direct invasion. This leads to the concept of a as reconstrucꢀve and vascular surgery, to ensure
“
planned posiꢀve margin,” which refers to areas where oncological resecꢀon and maximize the likelihood
wide margins cannot be achieved due to the proximity of limb preservaꢀon in cases of extremity tumors.
Referencias bibliográficas /References
1
2
.
.
Brennan MF, Antonescu CR, Moraco N, Singer S. Lessons lear-
ned from the study of 10,000 paꢀents with soꢁ ꢀssue sarcoma.
Ann Surg. 2014;260(3):416-21; discussion 421-2. doi:10.1097/
SLA.0000000000000869.
Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S,
et al. Soꢁ ꢀssue and visceral sarcomas: ESMO-EURACAN-GEN-
TURIS Clinical Pracꢀce Guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 2021;32(11):1348-65. doi:10.1016/j.an-
nonc.2021.07.006.
NCCN Guidelines® in Soꢁ Tissue Sarcoma. Version 1.2025.
Danieli M, Barreꢄa F, Fiore M, Radaelli S, Sangalli C, Barisella M,
et al. Refining the approach to paꢀents with primary soꢁ ꢀssue
sarcoma of the extremiꢀes and trunk wall: outcome improvement
over ꢀme at a single insꢀtuꢀon. Ann Surg Oncol. 2022;29(5):3274-
tes con sarcoma sinovial tratados quirúrgicamente. Medicina (B
Aires). 2023;83(5):737-43. PMID:37870331.
13. Norte MF, Recanaꢅ M, Juárez M de los Á, Montesinos MR, Debonis
DL. Experiencia en el tratamiento de sarcomas de partes blandas de
cabeza y cuello en el adulto. Rev Argent Cirug. 2016;108(3):125-9.
14. Pradier RN, González AR, Adan RS, Saco PA, Califano LL, Loria D, et
al. Sarcomas de partes blandas. Rev Argent Cirug. 1993;64:26-35.
15. Quildrian SD, Biscochea J, Calónico N, Chapela J, Sokol G, Cortés
Bellomo A y col. Rabdomiosarcoma de partes blandas del adulto.
Rev Argent Cirug. 2007;93(1-2):8-12.
3
4
.
.
16. Quildrian SD, Sokol G, Biscochea JC, López Moris E, Calónico N,
Chapela J y col. Liposarcoma de tronco y extremidades. Rev Ar-
gent Cirug. 2009;96(5-6):181-5.
17. Quildrian SD, Nardi WS, Vega MG, Chapela JA. The role of free
flap reconstrucꢀon aꢁer resecꢀon of extremity and trunk soꢁ
ꢀssue sarcomas. Clin Surg Oncol. 2024;3(2):10042. doi:10.1016/j.
cson.2024.100042.
18. Sylvestre Begnis G, Sylvestre Begnis D, Viú Armengol R, Grunfeld P,
Rastelli C. Sarcomas de partes blandas: resultados de tratamiento
y factores pronósꢀcos. Rev Argent Cirug. 2002;82(5-6):199-206.
19. Yanzon A, Gómez NL, Picco P, Boccalaꢄe L, Cayol F, Larrañaga J,
et al. Head and neck sarcomas: treatment outcomes in a terꢀary
referral center in Argenꢀna. Oral Maxillofac Surg. 2021;25(4):509-
18. doi:10.1007/s10006-021-00944-0.
20. Pasquali S, Palmerini E, Quagliuolo V, Marꢀn-Broto J, López-Pousa
A, Grignani G, et al. Neoadjuvant chemotherapy in high-risk soꢁ
ꢀssue sarcomas: a Sarculator-based risk straꢀficaꢀon analysis of
the ISG-STS 1001 randomized trial. Cancer. 2022;128(1):85-93.
doi:10.1002/cncr.33895.
8
6. doi:10.1245/s10434-021-11189-2.
5
6
.
.
Gervais MK, Basile G, Dulude JP, Moꢄard S, Gronchi A. Histolo-
gy-tailored approach to soꢁ ꢀssue sarcoma. Ann Surg Oncol.
2
024;31(12):7915-29. doi:10.1245/s10434-024-15981-8.
Gronchi A, Miceli R, Colombo C, Collini P, Stacchioꢅ S, Olmi P, et
al. Primary extremity soꢁ ꢀssue sarcomas: outcome improvement
over ꢀme at a single insꢀtuꢀon. Ann Oncol. 2011;22(7):1675-81.
doi:10.1093/annonc/mdq643.
7
8
9
.
.
.
Roland CL, van Houdt W, Gronchi A. The Landmark Series: mul-
ꢀ
modality treatment of extremity sarcoma. Ann Surg Oncol.
020;27(10):3672-82. doi:10.1245/s10434-020-08872-1.
2
Califano L, Saco P, González A, Adan R, Voogd A, Urruꢀa G y col.
Sarcomas de cabeza y cuello. Experiencia del Insꢀtuto Roffo. Rev
Argent Cirug. 2002;82(3-4):141-8.
Loccisano MH, Montesinos MF, Brégoli PA, Paradeda E, Avagni-
na A, Montesinos MR. Resultados del tratamiento quirúrgico de
los sarcomas de partes blandas en adultos. Rev Argent Cirug.
21. Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G,
et al. Histotype-tailored neoadjuvant chemotherapy versus stan-
dard chemotherapy in paꢀents with high-risk soꢁ-ꢀssue sarcomas
(ISG-STS 1001): an internaꢀonal, open-label, randomised, contro-
lled, phase 3, mulꢀcentre trial. Lancet Oncol. 2017;18(6):812-22.
doi:10.1016/S1470-2045(17)30334-0.
2
021;111(3):143-61.
1
1
0. Montesinos MR, Falco JE, Sinagra DL, Mezzadri NA, Curutchet HP.
Sarcomas retroperitoneales. Rev Argent Cirug. 2000;78:1-5.
1. Nardi W, Aragone L, Quildrian S. Primary treated versus refe-
rred trunk and extremiꢀes soꢁ ꢀssue sarcomas: comparaꢀve
analysis of iniꢀal treatment impact on disease control. ecancer.
22. Blay JY, Honoré C, Stoeckle E, Meeus P, Jafari M, Gouin F, et al. Sur-
gery in reference centers improves survival of sarcoma paꢀents:
a naꢀonwide study. Ann Oncol. 2019;30(7):1143-53. doi:10.1093/
annonc/mdz124.
2
025;19:1933. doi:10.3332/ecancer.2025.1933.
1
2. Novillo M, Albergo JI, Huespe I, Latallade V, Farfalli GL, Ayerza MA
y cols.. Resultados oncológicos y factores pronósꢀcos en pacien-
23. AbbasJS,HolyokeED,MooreR,KarakousisCP.Thesurgicaltreatment